Column Group LLC Long-Term Concentrated

CIK: 0001833486 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value ($000): $69,578 (100.0% shares, 0.0% debt)

Holdings (6)

ORIC ORIC Pharmaceuticals Inc. 52.2%

Value ($000) $36,293 Shares 3,540,777 Est. Cost $28.69 Unrealized -65.5%

TNYA Tenaya Therapeutics, Inc. 26.1%

Value ($000) $18,143 Shares 9,400,290 Est. Cost $21.49 Unrealized -86.9%

— Surrozen, Inc. 13.9%

Value ($000) $9,705 Shares 810,088 Est. Cost $7.82 Unrealized —

— RAPT Therapeutics Inc 7.7%

Value ($000) $5,388 Shares 2,680,621 Est. Cost $19.03 Unrealized —

SGMT Sagimet Biosciences Inc. 0.1%

Value ($000) $48 Shares 17,169 Est. Cost $7.18 Unrealized -57.1%

RVMD Revolution Medicines Inc 0.0%

Value ($000) $2 Shares 46 Est. Cost $34.24 Unrealized +27.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ORIC	ORIC Pharmaceuticals Inc.	3,540,777	$36,293	52.2%	$28.69	-65.5%	COM	68622P109
TNYA	Tenaya Therapeutics, Inc.	9,400,290	$18,143	26.1%	$21.49	-86.9%	COM	87990A106
—	Surrozen, Inc.	810,088	$9,705	13.9%	$7.82	—	COM	86889P109
—	RAPT Therapeutics Inc	2,680,621	$5,388	7.7%	$19.03	—	COM	75382E109
SGMT	Sagimet Biosciences Inc.	17,169	$48	0.1%	$7.18	-57.1%	COM	786700104
RVMD	Revolution Medicines Inc	46	$2	0.0%	$34.24	+27.2%	COM	76155X100